Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.
about
Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epitheliaPathogenesis of human immunodeficiency virus infectionSecretory responses of intact glomus cells in thin slices of rat carotid body to hypoxia and tetraethylammoniumHuman immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41Maternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective studyNeutralization-Enhancing RF Antibodies for HIV VaccinesThe effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogensWhy are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strainsTransmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveysPre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse modelActivation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytesInfection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodiesSubtype cross-reactive, infection-enhancing antibody responses to influenza A virusesFc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cellsMonoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophagesAntibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaquesMolecular mechanisms of antibody-mediated neutralisation of flavivirus infectionVaccination with a live retrovirus: the nature of the protective immune responseAntibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination StrategiesImmune-mediated thrombocytopenia in horses infected with equine infectious anemia virusExpression of CD4 by human megakaryocytes.Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic miceAn envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades.Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral loadAntibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzeesAntibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus.Lentiviruses are etiological agents of chronic diseases in animals and acquired immunodeficiency syndrome in humans.Options and obstacles for designing a universal influenza vaccineConstruction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins oDistinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120.Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis.Back to the future: covalent epitope-based HIV vaccine development.Current approaches to vaccine preparation.Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasmaRGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathwayPredictors of survival in human immunodeficiency virus type 1-seropositive intravenous drug users
P2860
Q24538755-58114D2C-EDBE-43A6-AEB9-CABE355B8654Q24541451-17013CC1-B7FF-4A4A-B894-1138251B1EE1Q24634681-9A99898B-160C-4916-82C9-8309E01220C8Q24674593-F4F0025F-52EF-4874-8537-5098F1BA9064Q24675546-0EAB46B0-0404-4650-A498-840F54B5ED0CQ24804378-9C6BD059-ADB6-4E9D-BAF3-48C09CE9A7FAQ27002322-3539128C-072D-4682-B7AF-F7B3185FDD73Q27473404-6CE86C4B-BE42-469E-BB11-6F3333088E8FQ27477749-8F5EB8DB-8B79-4F13-A228-42A9314772B5Q27477752-A8EB5551-180C-4ABF-87B8-BEE90DBFF754Q27480808-A81C08CA-E918-4D56-8B8E-22F91E3D4142Q27480826-C59A2359-2525-4E66-B29B-6DDC086CACC4Q27485071-56F5864E-812C-4AA3-83F4-C58A853E89B6Q27485986-0D50C88F-6184-42D0-9AD6-16D0AB0E8FB6Q27486208-86E131FB-A4BB-429F-AF99-96AF779BC6FDQ27486215-3719A9F4-8BF5-4C75-BE8C-295D86B8E426Q27486549-2FF64621-1D42-431A-B09D-DDD469D7A512Q27488337-38B1CAB8-26EC-4967-8500-93C8E1DD9F0AQ28335614-574CF0F4-AD70-4728-B3B8-322EF900BA64Q30408097-A989ECB6-E0F2-490C-83F3-650F251CD3B7Q33373647-479A864D-452A-4B63-847F-59A103723D6FQ33399873-2AEC5F64-EAE9-46C9-9035-FDCD09F7F18DQ33647876-FE6EA4A5-8D4E-4C2D-B9D4-46F567B29394Q33782446-5B58C4E1-48C6-4519-A4AF-5E0C10DF26C0Q33784679-517D5812-DA51-4024-BE25-00806CF3BB7EQ33813426-9B73619C-FDFD-42B8-A9CF-5AB2E58D4973Q33864057-1FB713F2-7910-460B-8B6E-5AE7B8E65C33Q33900233-66195C0D-A9C3-4349-9FE8-4F7E6070CEE4Q33937698-D6CFBBE4-3AFF-4E57-9556-A43BC4280759Q34081147-27135A1D-D6BA-451B-8EB4-6A6EA08D9683Q34102290-31B60418-F62B-4B5E-9D79-3296EA29C8FFQ34197974-D450D693-89D2-41FD-A88C-F2C5F30A9F94Q34209063-66CD845C-CF94-4C89-9606-30228DD75D3DQ34221143-2F5A6C32-D577-433C-92D0-E0253829D223Q34523443-6D5E1031-A5CD-47D8-AB4C-8C3C15E5A205Q34597300-7AE69E4C-E207-481E-9DE3-A493740B694BQ34688016-48966BB5-C7A5-44BC-B923-7A3DB1B835CCQ34702647-7A808494-594A-4018-ADDE-C8F03CA65F83Q35082522-19E1862F-0824-4562-AE7D-F25C0082D648Q35225429-7DC28A56-6C53-465C-9DF5-81076F471B11
P2860
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.
@en
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.
@nl
type
label
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.
@en
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.
@nl
prefLabel
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.
@en
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.
@nl
P2093
P356
P1433
P1476
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.
@en
P2093
P304
P356
10.1126/SCIENCE.2972065
P407
P577
1988-10-01T00:00:00Z